GAL3ST1
Galactosylceramide sulfotransferase is an enzyme that in humans is encoded by the GAL3ST1 gene.[5][6][7]
Sulfonation, an important step in the metabolism of many drugs, xenobiotics, hormones, and neurotransmitters, is catalyzed by sulfotransferases. The product of this gene is galactosylceramide sulfotransferase which catalyzes the conversion between 3'-phosphoadenylylsulfate + a galactosylceramide to adenosine 3',5'-bisphosphate + galactosylceramide sulfate. Activity of this sulfotransferase is enhanced in renal cell carcinoma.[7]
References
- 1 2 3 GRCh38: Ensembl release 89: ENSG00000128242 – Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000049721 – Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ Sanger Centre T, Washington University Genome Sequencing Cente T (November 1998). "Toward a complete human genome sequence". Genome Research. 8 (11): 1097–1108. doi:10.1101/gr.8.11.1097. PMID 9847074.
- ↑ Honke K, Tsuda M, Hirahara Y, Ishii A, Makita A, Wada Y (April 1997). "Molecular cloning and expression of cDNA encoding human 3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase". The Journal of Biological Chemistry. 272 (8): 4864–4868. doi:10.1074/jbc.272.8.4864. PMID 9030544.
- 1 2 "Entrez Gene: GAL3ST1 galactose-3-O-sulfotransferase 1".
Further reading
- Siegrist HP, Jutzi H, Steck AJ, Burkart T, Wiesmann U, Herschkowitz N (October 1977). "Age-dependent modulation of 3'-phosphoadenosine-5'-phosphosulfate-galactosylceramide sulfotransferase by lipids extracted from the microsomal membranes and artificial lipid mixtures". Biochimica et Biophysica Acta. 489 (1): 58–63. doi:10.1016/0005-2760(77)90231-4. PMID 911873.
- Stein C, Gieselmann V, Kreysing J, Schmidt B, Pohlmann R, Waheed A, et al. (January 1989). "Cloning and expression of human arylsulfatase A". The Journal of Biological Chemistry. 264 (2): 1252–1259. doi:10.1016/S0021-9258(19)85079-2. PMID 2562955.
- Fleischer B, Zambrano F (1973). "Localization of cerebroside-sulfotransferase activity in the Golgi apparatus of rat kidney". Biochemical and Biophysical Research Communications. 52 (3): 951–958. doi:10.1016/0006-291X(73)91029-2. PMID 4710574.
- Farrell DF, McKhann GM (1971). "Characterization of cerebroside sulfotransferase from rat brain". The Journal of Biological Chemistry. 246 (15): 4694–4702. doi:10.1016/S0021-9258(18)61991-X. PMID 5562350.
- Costantino-Ceccarini E, Waehneldt TV, Ginalski H, Burgisser P, Reigner J, Matthieu JM (January 1982). "Distribution of lipid synthesizing enzymes, 2',3'-cyclic nucleotide 3'-phosphodiesterase, and myelin proteins in rat forebrain subfractions during development". Neurochemical Research. 7 (1): 1–12. doi:10.1007/BF00965064. PMID 6280086. S2CID 32069166.
- Benjamins JA, Hadden T, Skoff RP (1982). "Cerebroside sulfotransferase in Golgi-enriched fractions from rat brain". Journal of Neurochemistry. 38 (1): 233–241. doi:10.1111/j.1471-4159.1982.tb10875.x. PMID 6955451. S2CID 23693243.
- Honke K, Yamane M, Ishii A, Kobayashi T, Makita A (March 1996). "Purification and characterization of 3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase from human renal cancer cells". Journal of Biochemistry. 119 (3): 421–427. doi:10.1093/oxfordjournals.jbchem.a021258. PMID 8830034.
- Tsuda M, Egashira M, Niikawa N, Wada Y, Honke K (May 2000). "Cancer-associated alternative usage of multiple promoters of human GalCer sulfotransferase gene". European Journal of Biochemistry. 267 (9): 2672–2679. doi:10.1046/j.1432-1327.2000.01281.x. PMID 10785389.
- Eckhardt M, Fewou SN, Ackermann I, Gieselmann V (2002). "N-glycosylation is required for full enzymic activity of the murine galactosylceramide sulphotransferase". The Biochemical Journal. 368 (Pt 1): 317–324. doi:10.1042/BJ20020946. PMC 1222978. PMID 12175333.
- Collins JE, Wright CL, Edwards CA, Davis MP, Grinham JA, Cole CG, et al. (2004). "A genome annotation-driven approach to cloning the human ORFeome". Genome Biology. 5 (10) R84. doi:10.1186/gb-2004-5-10-r84. PMC 545604. PMID 15461802.




